Please login to the form below

Not currently logged in
Email:
Password:

disease progression

This page shows the latest disease progression news and features for those working in and with pharma, biotech and healthcare.

AZ makes case for first-line Tagrisso therapy in lung cancer

AZ makes case for first-line Tagrisso therapy in lung cancer

The company says post-progression data - which evaluates the time between disease progression on the first-line therapy to the start of second- or late-line therapy - reinforces the benefit of ... Earlier data from FLAURA have shown that AZ’s drug

Latest news

More from news
Approximately 1 fully matching, plus 220 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to. ... Curative therapies have the potential to offset

  • A quest for innovative solutions A quest for innovative solutions

    disease progression. ... It is important that patients can see the value in tracking their disease.

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... To show the stopping of disease progression can take a couple of years and that is a long time to conduct a clinical trial, so we hope we can

  • Accelerating innovation Accelerating innovation

    The new trial of previously untreated patients with advanced RCC showed a 52% reduction in the rate of disease progression or death compared to Sutent, with Cabometyx showing median progression-free

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    to describe disease onset and progression in whole new ways, as well as therapeutic impact, and to develop digital biomarkers to deliver more proactive care to patients based on their everyday ... products but others, patients feel empowered and

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest appointments

  • PatientsLikeMe names Jason Johnson as head of R&D PatientsLikeMe names Jason Johnson as head of R&D

    Johnson will lead the company's research, data science and informatics teams, which focus on analysing and merging patient-reported data and other data types to develop models of disease progression ... and generate new insights about disease, treatments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • emotive shortlisted for four awards at the PM Digital Awards 2016

    For the first time, cardiologists can explore in detail the inside of different patients’ beating hearts, experience the symptoms and comorbidities of aortic stenosis, and change the disease’ s severity to ... Innovation. The second is

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    so.Unfortunately, the complexity of the disease has meant that many recent AD trials have been unsuccessful. ... only capable of slowing the progression of disease symptoms.

  • Changing behaviour by design

    Loss aversion may also be applied to physician decision-making, while determining medication risk in relation to gains in quality of life, survival or disease-free progression etc, and when conveying

  • Living with Crohn's disease: a patient perspective

    What is it like to live with a  chronic disease in your 20s? ... Despite progression in our knowledge of this condition, there is still a relatively poor understanding of this complex disease area, which inherently makes diagnosis even more difficult.

  • Immunotherapy in oncology

    These three states align with the clinical observations of response, stable disease and progression of disease. ... With immunotherapies, even patients with stable disease have experienced significant survival benefit while responders have far exceeded

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics